CD38-IN-78c is a drug which acts as a potent and selective inhibitor of the glycoprotein enzyme CD38.

[1] In animal studies it boosts levels of nicotinamide adenine dinucleotide (NAD+) in tissues via inhibition of CD38 mediated breakdown of nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN), and has been shown to ameliorate metabolic dysfunction associated with the aging process.

[2] It also has potential therapeutic application in the treatment of asthma.

This pharmacology-related article is a stub.

You can help Wikipedia by expanding it.